본문 바로가기

Successful cryopreservation of mouse and human blastocysts using vitrification solution without sucrose and Ficoll

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q4Scopus Q4
피인용
Web of Science 1Scopus 1
FWCI (Scopus)
0
JCR IF
JCR 2019 0.139
ISSN
0390-6663

저자

  1. Kim, C. W.제1저자Department of Obstetrics and Gynecology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon (Republic of Korea)
  2. 이동형Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan 49241 (Republic of Korea)
  3. 주보선교신저자Infertility Institute, Pohang Women's Hospital, Pohang 37754 (Republic of Korea)
  4. 이규섭교신저자Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan 49241 (Republic of Korea)

초록

Purpose of Investigation: This study investigated whether cryopreservation of mouse and human blastocysts using vitrification solutions formulated with or without sucrose and Ficoll affects survival rate and pregnancy outcome. Materials and Methods: Two-cell mouse embryos were retrieved from C57BL/CBA females aged 5 weeks and cultured to the blastocyst stage. Artificial shrinkage of blastocysts was performed by blastocoel fluid aspiration before vitrification and then exposed to and vitrified-warmed in one of four different vitrification solutions: 1) 25% glycerol, 25% ethylene glycol, 20% SSS and PBS without sucrose and Ficoll (G25E25), 2) G25E25 with 0.5 M sucrose (G25E25S0.5), 3) G25E25 with 10 mg/mL Ficoll (G25E25F10), and 4) G25E25 with 0.5 M sucrose and 10mg/mL Ficoll (G25E25S0.5F10). Second, in 435 infertile women undergoing in vitro fertilization and embryo transfer (IVF-ET), artificially shrunken blastocysts were vitrified-warmed either in G25E25 (n = 206) and G25E25S0.5F10 (n = 229). Results: In the mouse series, in vitro survival rates of post-warm blastocysts were 93, 91, 90, and 90% in G25E25, G25E25S0.5, G25E25F10, and G25E25S0.5F10, respectively. No significant differences among four groups were found. In the human series, in vitro survival rates and clinical pregnancy rate of blastocysts vitrified-warmed in G25E25 were 96 and 53.3%, respectively, which were similar to those in G25E25S0.5F10 (92 and 51.9%, respectively). Conclusions: Sucrose- and Ficoll-free vitrification solutions can be successfully cryopreserved mouse and human blastocysts without compromising survival rate and pregnancy outcome.

키워드

BlastocystVitrificationSucroseFicollSurvivalPregnancy outcomeLASER-PULSE PRIORARTIFICIAL SHRINKAGEBLASTOCOELE COLLAPSEEMBRYO-TRANSFERCLEAVAGE-STAGESURVIVALCELLS

식별자

Scopus EID
2-s2.0-85099157127
WoS UID
000598997300007